105 related articles for article (PubMed ID: 32463170)
21. Crescentic glomerulonephritis developing in the course of idiopathic membranoproliferative glomerulonephritis.
Sharma A; Gupta R; Lal C; Agarwal SK; Dinda AK
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):333-7. PubMed ID: 23538361
[TBL] [Abstract][Full Text] [Related]
22. Clinical presentation, treatment and outcome of focal segmental glomerulosclerosis in Far North Queensland Australian adults.
Greenwood AM; Gunnarsson R; Neuen BL; Oliver K; Green SJ; Baer RA
Nephrology (Carlton); 2017 Jul; 22(7):520-530. PubMed ID: 27170059
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy.
Oh HJ; Ahn SV; Yoo DE; Kim SJ; Shin DH; Lee MJ; Kim HR; Park JT; Yoo TH; Kang SW; Choi KH; Han SH
Kidney Int; 2012 Dec; 82(12):1304-12. PubMed ID: 22895518
[TBL] [Abstract][Full Text] [Related]
24. [Factors predicting chronic renal failure in membranoproliferative glomerulonephritis].
Dobronravov VA
Klin Med (Mosk); 1996; 74(7):29-33. PubMed ID: 8992108
[TBL] [Abstract][Full Text] [Related]
25. Association between plasma phosphorus and renal outcome: A prospective cohort of patients majorly with glomerulonephritis.
Xu D; Lv J; Wang J; Zhang L; Zhang H
Nephrology (Carlton); 2017 Jan; 22(1):43-48. PubMed ID: 26769231
[TBL] [Abstract][Full Text] [Related]
26. Serum C3/C4 ratio is a novel predictor of renal prognosis in patients with IgA nephropathy: a retrospective study.
Pan M; Zhou Q; Zheng S; You X; Li D; Zhang J; Chen C; Xu F; Li Z; Zhou Z; Zhang J
Immunol Res; 2018 Jun; 66(3):381-391. PubMed ID: 29850970
[TBL] [Abstract][Full Text] [Related]
27. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
[TBL] [Abstract][Full Text] [Related]
28. Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative) glomerulonephritis.
Cansick JC; Lennon R; Cummins CL; Howie AJ; McGraw ME; Saleem MA; Tizard EJ; Hulton SA; Milford DV; Taylor CM
Nephrol Dial Transplant; 2004 Nov; 19(11):2769-77. PubMed ID: 15385635
[TBL] [Abstract][Full Text] [Related]
29. Canine IgA glomerulonephropathy.
Harris CH; Krawiec DR; Gelberg HB; Shapiro SZ
Vet Immunol Immunopathol; 1993 Feb; 36(1):1-16. PubMed ID: 8447084
[TBL] [Abstract][Full Text] [Related]
30. Analysis of clinical presentation, pathological spectra, treatment and outcomes of biopsy-proven acute postinfectious glomerulonephritis in adult indigenous people of the Northern Territory of Australia.
Ramanathan G; Abeyaratne A; Sundaram M; Fernandes DK; Pawar B; Perry GJ; Sajiv C; Majoni SW
Nephrology (Carlton); 2017 May; 22(5):403-411. PubMed ID: 27062647
[TBL] [Abstract][Full Text] [Related]
31. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
32. [Risk factors affecting the long-term outcome of IgA nephropathy].
Yang NS; Wu QQ; Du Y; Zhang R; Li YJ; Ye RG; Yu XQ
Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):597-600. PubMed ID: 16194415
[TBL] [Abstract][Full Text] [Related]
33. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
[TBL] [Abstract][Full Text] [Related]
34. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
Park GY; Yu CH; Kim JS; Kang YJ; Kwon O; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
[TBL] [Abstract][Full Text] [Related]
35. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
Tian S; Yang X; Luo J; Guo H
Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
[TBL] [Abstract][Full Text] [Related]
36. Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopatological classification schema and review of the literature.
Moroni G; Binda V; Leoni A; Raffiotta F; Quaglini S; Banfi G; Messa P
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-56-63. PubMed ID: 26016751
[TBL] [Abstract][Full Text] [Related]
37. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes of IgA nephropathy patients with different proportions of crescents.
Zhang W; Zhou Q; Hong L; Chen W; Yang S; Yang Q; Chen W; Yu X
Medicine (Baltimore); 2017 Mar; 96(11):e6190. PubMed ID: 28296731
[TBL] [Abstract][Full Text] [Related]
39. Crescentic glomerulonephritis in children.
Jardim HM; Leake J; Risdon RA; Barratt TM; Dillon MJ
Pediatr Nephrol; 1992 May; 6(3):231-5. PubMed ID: 1352123
[TBL] [Abstract][Full Text] [Related]
40. Renal Outcomes in Brazilian Patients with Immunoglobulin A Nephropathy and Cellular Crescentic Lesions.
Neves PDMM; Pinheiro RBB; Dias CB; Yu L; Testagrossa LA; Cavalcante LB; Malheiros DMAC; Jorge LB; Woronik V
Kidney Blood Press Res; 2020; 45(3):431-441. PubMed ID: 32299081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
